Rishi Chanderraj is an Infectious Disease physician affiliated with Environmental Research Institute of Michigan. OpenAlex indexes 58 publications with 1,751 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 E Medical Center Dr
Ann Arbor, MI 481095000
Telephone
734-936-4000Registry record last updated 3 Jul 2019.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- bioMerieux IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Penicillins with extended spectrum57.1%Amoxicillin-Clavulanate Potass100%Part D<11 patientsShort-acting sulfonamides42.9%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2025 per NIH RePORTER. The latest:
- Impact of anti-anaerobic antibiotics on clinical outcomes and the microbiome in hospitalized Veterans
Veterans Health Administration
FY2025IK2CX002766 - Impact of anti-anaerobic antibiotics on clinical outcomes and the microbiome in hospitalized Veterans
Veterans Health Administration
FY2024IK2CX002766
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pathogen characteristics are key determinants of distinct host response phenotypes of sepsis
Journal of Clinical Investigation
2026 - Association of White Blood Cell Count with Treatment Response to Cefepime vs Piperacillin-Tazobactam
American Journal of Respiratory and Critical Care Medicine
2026 - Reply to Hamilton <i>et al</i> . and chen <i>et al</i>
American Journal of Respiratory and Critical Care Medicine
2026 - Antianaerobic Antibiotics, Gut Microbiota, and Sepsis-associated Acute Kidney Injury
American Journal of Respiratory and Critical Care Medicine
2025 - Epidemiology of positive bacterial cultures and the coverage gaps in multiplex PCR diagnostics: a single-center retrospective study
Journal of Clinical Microbiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”